Canada Womens Health Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 1.97 Bn

Forecast Year, 2035

USD 3.38 Bn

CAGR, 2026 - 2035

5.52%

Report Coverage

Canada

What is Canada Womens Health Market Size?

The canada womens health market size is calculated at USD 1.97 billion in 2025 and is predicted to increase from USD 2.08 billion in 2026 to approximately USD 3.38 billion by 2035, expanding at a CAGR of 5.52% from 2026 to 2035. The market is experiencing rapid growth to bridge the gap between women's deteriorating health and its adverse effects on the country's GDP, to increase awareness of proactive healthcare solutions, and to grow the FemTech domain in Canada.

Market Highlights

• By application/condition, the postmenopausal osteoporosis segment held the largest market share in 2025
• By application/condition, the menopause segment is set to grow at the highest CAGR from 2026 to 2035.
• By product/drug class, the hormonal therapies segment contributed the highest market share in 2025.
• By product/drug class, the digital therapeutics segment is expected to expand at a strong CAGR from 2026 to 2035.
• By care settings/channels, the hospitals/specialty clinics segment accounted for the major market share in 2025.
• By care settings/channels, the online pharmacies & digital health platforms segment is growing at a healthy CAGR from 2026 to 2035.

Canada Women's Health Market- Evolving Healthcare Approach of Women

The Canada women's health market covers products, services, and technologies addressing women's sexual and reproductive health, fertility, menopausal care, bone health, gynaecological disorders such as endometriosis, uterine fibroids, and PCOS, contraceptives, and related diagnostics, devices, and digital or fintech solutions. It further includes prescription drugs such as hormonal therapies, fertility agents, and bone health agents, as well as devices, diagnostics, clinic services for fertility, IVF, and gynaecology, and consumer fintech and digital health offerings targeted at female health needs. This landscape reflects a broad shift in the region toward improving access to specialized care, strengthening preventive health systems, and supporting long-term well-being for women across different age groups.

The evolving landscape of women's healthcare products in Canada is driven by increasing demand for targeted therapeutic options, rising awareness of chronic gynaecological conditions, and the growing recognition of gender specific health needs within clinical practice. Canadian healthcare providers increasingly diagnose conditions such as endometriosis and PCOS earlier due to improved screening tools and updated clinical guidance. This encourages wider use of advanced diagnostics and minimally invasive devices that support faster detection and more personalized treatment pathways. Investments in fertility clinics and IVF infrastructure across major provinces also reflect demographic and societal changes, as more women plan pregnancies later in life and seek medically supported fertility options.

AI Shifts in Canada's Women's Health Market

The incorporation of cutting-edge technologies like artificial intelligence into healthcare companies-primarily dedicated to offering women's health-related solutions in Canada, is majorly transforming Canada women's healthcare landscape. Leading femtech companies like Eli Health, Future Fertility, COSM Medical Corp, HerSay, and many others are offering solutions and innovative products related to women's health that are powered by AI.

For example, Eli Health is a leading Canadian femtech company that offers an AI-powered smart device, engineered to analyze saliva samples of women that present a hormone profile at home, precisely assisting women to follow their reproductive health via an AI-based mobile application accompanied by the smart device.

Women are becoming more comfortable detecting early signs of diseases by using AI-powered products like the SELF Menopause testing kit, regulated by Health Canada. AI-based apps and direct-to-consumer platforms for disease detection, reproductive health tracking, along with remote health consulting, are key drivers of the femtech business of Canada, impacting the growth of Canada women's health market positively.

Canada Women's Health Market Outlook

[[market_outlook]]

Market Scope

Segmental Insights

[[segment_insights]]

Country-level Analysis

Ontario and Quebec lead the Canada women's health market due to their large populations, dense healthcare networks, and strong concentration of specialized clinical services. These provinces host the highest number of fertility centres, gynaecology clinics, menopause programs, and diagnostic facilities in the country. This creates consistent demand for prescription therapies, imaging services, and digital health offerings targeted at women's health needs.

Ontario benefits from a broad hospital system and a large academic research base. Major centres in Toronto, Ottawa, and Hamilton support advanced programs in reproductive medicine, oncology , endocrinology, and pelvic health. This ecosystem attracts investment from device manufacturers, pharmaceutical companies , and digital health firms that focus on women's health innovation. The presence of large teaching hospitals also accelerates the adoption of updated clinical guidelines, which increases the use of specialized diagnostics and treatments.

Quebec shows similar strengths. Montreal and Quebec City house highly developed reproductive and gynaecological care networks. These centres provide IVF, minimally invasive gynaecological procedures, menopause care, and chronic condition management for disorders such as endometriosis and PCOS. Quebec's structured provincial health programs encourage routine screening and early intervention, which drives the use of diagnostics, hormonal therapies, and long-term condition management tools. Both provinces carry a significant share of Canada's ageing female population. This increases demand for services related to menopause, bone health, chronic disease prevention, and cardiovascular risk management.

Value Chain Analysis of Canada Women's Health Market

[[value_chain]]

Companies in Canada Women's Health Market

• AbbVie Inc.
• Bayer AG
• Merck & Co., Inc. (MSD)
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• Ferring Pharmaceuticals
• Amgen Inc.
• Acerus Pharmaceuticals
• Laborie Medical Technologies
• FemTherapeutics Inc.
• Eli (Eli Health)
• Hyivy Health
• Products by Women
• CCRM Fertility (CCRM Canada)
• CReATe Fertility Centre
• Olive Fertility Centre
• NewLife / TRIO / IVF Canada
• McKesson Canada
• Hologic
• CooperSurgical
• Karl Storz
• Femtech Canada

Segments Covered in the Report

[[segment_covered]]